What MIRA Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Aminov Erez | CEO and Chairman | Oct 16 | Open-market sale · S | −613,595 | $2.11 | −$1.29M | 3,592,666 |
| Aminov Erez | CEO and Chairman | Oct 16 | Exercise / conversion · M | +379,000 | $0.84 | +$318K | 4,206,259 |
| Aminov Erez | CEO and Chairman | Oct 16 | Exercise / conversion · M | +234,595 | $1.16 | +$272K | 3,827,259 |
| Aminov Erez | Chief Executive Officer | Oct 01 | Grant / award · A | +2,685,456 | — | — | 3,530,156 |
| Shekhat Denil Nanji | Director | Oct 01 | Grant / award · A | +22,378 | $1.35 | +$30.2K | 22,378 |
| Aminov Erez | Chief Executive Officer | Aug 29 | Grant / award · A | +62,500 | $1.37 | +$85.6K | 844,700 |
| Aminov Erez | CEO and Chairman | Mar 26 | Grant / award · A | +62,500 | $1.45 | +$90.6K | 3,592,666 |
| Aminov Erez | CEO and Chairman | Mar 26 | Grant / award · A | +62,500 | $1.45 | +$90.6K | 3,530,166 |
| Aminov Erez | Chief Executive Officer | Nov 20 | Disclosed 10b5-1 sale · S | −44,590 | $1.27 | −$56.6K | 1,061,200 |
| Aminov Erez | Chief Executive Officer | Nov 19 | Disclosed 10b5-1 sale · S | −55,410 | $1.39 | −$77K | 1,105,790 |
| McNulty Brian Patrick | 10% owner | Aug 28 | Open-market sale · S | −200,000 | $1.96 | −$392K | 2,540,270 |
| Aminov Erez | Chief Executive Officer | May 21 | Open-market buy · P | +800 | $0.97 | +$776 | 382,200 |
| Aminov Erez | Chief Executive Officer | May 21 | Open-market buy · P | +800 | $1.01 | +$808 | 381,400 |
| Aminov Erez | Chief Executive Officer | May 21 | Open-market buy · P | +600 | $0.87 | +$522 | 380,600 |
| Aminov Erez | Chief Executive Officer | May 21 | Open-market buy · P | +1,000 | $0.85 | +$850 | 380,000 |
| Aminov Erez | Chief Executive Officer | May 21 | Open-market buy · P | +2,000 | $0.84 | +$1.68K | 379,000 |
| Aminov Erez | Chief Executive Officer | May 21 | Open-market buy · P | +500 | $1.02 | +$510 | 377,000 |
| Aminov Erez | Chief Executive Officer | May 21 | Open-market buy · P | +1,000 | $1.03 | +$1.03K | 376,500 |
| Aminov Erez | Chief Executive Officer | May 21 | Open-market buy · P | +2,000 | $1.00 | +$2K | 375,500 |
| McNulty Brian Patrick | 10% owner | Dec 11 | Open-market sale · S | −23,002 | $1.55 | −$35.7K | 660,000 |
Loading...
